Crizotinib companion diagnostic - Abbott
Alternative Names: Abbott ALK test; ALK gene rearrangement diagnostic - Abbott; Vysis ALK Break Apart FISH Probe KitLatest Information Update: 06 Mar 2017
Price :
$50 *
At a glance
- Originator Abbott Laboratories
- Class Diagnostic agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Non-small cell lung cancer
Most Recent Events
- 06 Mar 2017 Launched for Non-small cell lung cancer (Diagnosis) in Taiwan, South Korea, Malaysia, and Japan (unspecified route) before March 2017
- 06 Mar 2017 No recent reports on development identified - Registered for Non-small cell lung cancer (Diagnosis) in Australia (unspecified route)
- 30 Aug 2011 Preregistration for Non-small cell lung cancer (diagnosis) in Asia (unspecified route)